Literature DB >> 20557848

First-line treatment of patients with metastatic pancreatic cancer: results of a Phase II trial with S-1 (CESAR-Study group).

D Strumberg1, L Bergmann, U Graeven, A Hanauske, R Lipp, J Schuette, B Schultheis, P Scigalla, P Urrea, M E Scheulen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20557848     DOI： 10.5414/cpp48470

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN： 0946-1965            Impact factor:   1.366


× No keyword cloud information.
  1 in total

Review 1.  Developments in metastatic pancreatic cancer: is gemcitabine still the standard?

Authors:  Jie-Er Ying; Li-Ming Zhu; Bi-Xia Liu
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.